The Effects of Social Presence on Adherence-Focused Guidance in Problematic Cannabis Users: Protocol for the CANreduce 2.0 Randomized Controlled Trial

Journals

1. Moreno-Rius J. The Cerebellum, THC, and Cannabis Addiction: Findings from Animal and Human Studies. The Cerebellum 2019;18(3):593 View
2. Malischnig D, Baumgartner C, Schaub M. CANreduce 2.0: Reduzierung des Cannabiskonsums unter Berücksichtigung von psychischen Komorbiditäten wie der Generalisierten Angststörung – Zwei Fliegen auf einen Schlag?. Suchttherapie 2020;21(04):194 View
3. Baumgartner C, Schaub M, Wenger A, Malischnig D, Augsburger M, Walter M, Berger T, Stark L, Ebert D, Keough M, Haug S. CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial. Journal of Medical Internet Research 2021;23(4):e27463 View
4. Baumgartner C, Schaub M, Wenger A, Malischnig D, Augsburger M, Lehr D, Blankers M, Ebert D, Haug S. “Take Care of You” – Efficacy of integrated, minimal-guidance, internet-based self-help for reducing co-occurring alcohol misuse and depression symptoms in adults: Results of a three-arm randomized controlled trial. Drug and Alcohol Dependence 2021;225:108806 View
5. Yang H, Peng Z, Guo X, Lai K. Balancing online pharmacy services for patient adherence: a stimulus-organism-response perspective. Internet Research 2021;31(6):2000 View
6. Dey M, Wenger A, Baumgartner C, Herrmann U, Augsburger M, Haug S, Malischnig D, Schaub M. Comparing a mindfulness- and CBT-based guided self-help Internet- and mobile-based intervention against a waiting list control condition as treatment for adults with frequent cannabis use: a randomized controlled trial of CANreduce 3.0. BMC Psychiatry 2022;22(1) View
7. Mestre-Pintó J, Fonseca F, Schaub M, Baumgartner C, Alias-Ferri M, Torrens M. CANreduce-SP—adding psychological support to web-based adherence-focused guided self-help for cannabis users: study protocol for a three-arm randomized control trial. Trials 2022;23(1) View
8. . Hands-off: Feasibility and preliminary results of a two-armed randomized controlled trial of a web-based self-help tool to reduce problematic pornography use. Journal of Behavioral Addictions 2021;10(4):1015 View
9. Ahlers J, Baumgartner C, Augsburger M, Wenger A, Malischnig D, Boumparis N, Berger T, Stark L, Ebert D, Haug S, Schaub M. Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis. Journal of Medical Internet Research 2022;24(4):e30138 View
10. Bőthe B, Baumgartner C, Schaub M, Demetrovics Z, Orosz G. Hands-off: Study protocol of a two-armed randomized controlled trial of a web-based self-help tool to reduce problematic pornography use. Journal of Behavioral Addictions 2020;9(2):433 View
11. Boumparis N, Noroozi A, Naghizadeh E, Meyer A, Wenger A, Rahimi-Movaghar A, Schaub M. Blended smartphone intervention for patients in opioid maintenance treatment in Iran: protocol for a randomized controlled trial. BMC Psychiatry 2023;23(1) View
12. Mohammadpanah M, Farrokhi S, Sani M, Moghaddam M, Bayat A, Boroujeni M, Abdollahifar M, Fathi M, Vakili K, Nikpour F, Omran H, Ahmadirad H, Ghorbani Z, Peyvandi A, Aliaghaei A. Exposure to Δ9-tetrahydrocannabinol leads to a rise in caspase-3, morphological changes in microglial, and astrocyte reactivity in the cerebellum of rats. Toxicology Research 2023;12(6):1077 View

Books/Policy Documents

1. Brezing C, Mitra S, Levin F. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. View
2. Fuss J, Bőthe B. Mental Health in a Digital World. View